The FDA always pulls in an independent advisory council on novel treatments, which mRNA vaccines still are, despite Pfizer's vaccine receiving approval.
Dotting the i's and crossing the t's.
Asking for advice from those much closer to the forefront of clinical research and medical science.
But the error is in following normal process in a health emergency.
Delaying release to hold the AdCom is error. They could have released the vaccine and then hold the Adcom.
The current ERROR going on is not releasing all the available doses, holding back doses for the second shot. We now have some data supporting a single dose effectiveness north of 80% for both $PFE and $MRNA vaccines.
I'm not suggesting the second dose not be given. But prioritizing the first dose, even if there is some slippage in the 3/4 week delta would minimize death and morbidity.
Market Data 
Markets 
AI
